Related Experiment Videos
Senescent fibroblasts resist apoptosis by downregulating caspase-3
Richard Marcotte1, Chantale Lacelle, Eugenia Wang
1The Bloomfield Center for Research in Aging, Lady Davis Institute for Medical Research, The Sir Mortimer B. Davis-Jewish General Hospital, and Department of Medicine, McGill University, Montréal, Québec, Canada.
Mechanisms of Ageing and Development
|November 16, 2004
Summary
Replicatively senescent fibroblasts resist cell death by downregulating caspase-3 activity. This resistance, coupled with high Bcl-2 levels, suggests senescent cells may be programmed to survive, not undergo apoptosis.
Area of Science:
- Cell Biology
- Aging Research
- Molecular Biology
Background:
- Replicative senescence involves permanent cell cycle exit.
- Senescence checkpoints are typically at the G(1)/S border.
- Senescent cells exhibit altered protein expression, including cell cycle inhibitors and reduced proliferation markers.
Purpose of the Study:
- To investigate the apoptotic resistance of replicatively senescent fibroblasts.
- To understand the molecular mechanisms underlying senescent cell survival.
- To explore the implications of non-proliferating, non-dying senescent cells in aging.
Main Methods:
- Analysis of cell cycle arrest in fibroblasts.
- Assessment of apoptotic markers and enzyme activities (e.g., caspase-3).
- Quantification of pro-survival factors (e.g., Bcl-2) in senescent cells.
Main Results:
- Replicatively senescent fibroblasts demonstrated resistance to apoptotic death.
- Key apoptotic enzyme activity, specifically caspase-3, was found to be lacking.
- Senescent fibroblasts maintained high levels of the pro-survival factor Bcl-2.
Conclusions:
- Senescent fibroblasts possess a molecular program that prevents apoptotic cell death.
- The inability to undergo apoptosis, alongside cell cycle arrest, defines a unique state for senescent cells.
- Further research is needed to determine the role of these persistent senescent cells in organismal aging and potential tissue detriment.